Q32 Bio Inc.
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Mar 2022 | $44.7M | $311.0M | $248.1M |
| Jun 2022 | $44.3M | $284.6M | $176.2M |
| Sep 2022 | $53.6M | $262.7M | $43.2M |
| Dec 2022 | $50.5M | $228.5M | $34.0M |
| Mar 2023 | $46.0M | $197.9M | $31.4M |
| Jun 2023 | $50.0M | $169.3M | $20.1M |
| Sep 2023 | $51.9M | $140.1M | $36.3M |
| Dec 2023 | $118.5M | $47.1M | $25.6M |
| Mar 2024 | $103.6M | $152.3M | $115.5M |
| Jun 2024 | $90.7M | $124.2M | $97.7M |
| Sep 2024 | $86.2M | $104.5M | $89.1M |
| Dec 2024 | $86.7M | $92.3M | $78.0M |
| Mar 2025 | $83.1M | $79.1M | $65.5M |
| Jun 2025 | $78.4M | $66.1M | $54.8M |
| Sep 2025 | $76.2M | $57.8M | $49.0M |
| Dec 2025 | $19.8M | $61.8M | $48.3M |
| Mar 2026 | $17.4M | $63.7M | $50.8M |
| Jun 2026 | $10.0M | $115.9M | $106.3M |